Hiromi Nagashima

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 626 citations

Interim Analysis, Oncology, Bevacizumab Versus Erlotinib +8

Intra-articular pressure of the hip joint outside and inside the limbus.

H. Takechi, Hiromi Nagashima, Seiji Ito · PubMed · 1982 · 78 citations

Kinesiology, Hip Joint, Internal Rotation +13

Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report

Yutaka Nakamura, Yu Utsumi, Naomi Suzuki et al. · Journal of Medical Case Reports · 2011 · 44 citations · Full text

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

Tatsuro Fukuhara, Haruhiro Saito, Naoki Furuya et al. · EBioMedicine · 2020 · 28 citations · Full text

Effect of Genetic Variation of IL-13 on Airway Remodeling in Bronchial Asthma

Hiromi Nagashima, Yutaka Nakamura, Hiroyuki Kanno et al. · Allergology International · 2011 · 18 citations · Full text